# Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

Source: https://onco.cc/trials/nct04275986/  
OnCo record `nct04275986` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Endoscopic resection in Oesophageal squamous cell carcinoma, run by Chinese Academy of Medical Sciences, with a status the registry has not verified recently.

## Summary

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma is a phase 2 interventional study registered as NCT04275986 by Chinese Academy of Medical Sciences, with 56 participants planned, started 2020-01-20 and due to reach its primary completion in 2024-01. Interventions recorded: Intensity modulated radiotherapy (IMRT), Chemotherapy. Conditions recorded: Esophageal Squamous Cell Carcinoma.

Linked to the technology Endoscopic resection because the registry's title names it ("endoscopic resection") and Oesophageal squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04275986
- Phase: 2
- Setting: A Phase II Clinical Trial of Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Squamous Cell Carcinoma
- Sponsor: Chinese Academy of Medical Sciences
- Enrolled: 56

## Sources

- ClinicalTrials.gov NCT04275986: https://clinicaltrials.gov/study/NCT04275986

## Connected records

- cancers: [Oesophageal squamous cell carcinoma](https://onco.cc/cancers/oesophageal-squamous-cell-carcinoma/)
- technologies: [Endoscopic resection (EMR / ESD)](https://onco.cc/technologies/endoscopic-resection/)

---
JSON: https://onco.cc/api/v1/entities/nct04275986.json